AIDS News and Research

RSS

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.

21 Jan 2010

New class of HCV inhibitors discovered by Eiger BioPharmaceuticals

Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.

21 Jan 2010

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

21 Jan 2010

Opinions: Haiti relief, recovery efforts

U.N. Secretary-General Ban Ki-Moon asserts in a Washington Post opinion piece that assistance "has poured forth from nations and international organizations commensurate with the scale of this disaster [in Haiti]. ... We need to make sure the help that is mobilized gets to the people who need it, as fast as possible.

21 Jan 2010

Circumcising newborn males cost effective strategy for HIV prevention, Rwandan study finds

Performing circumcisions on newborn boys to lower their risk for HIV infection later in life is more cost-effective than adolescent or adult circumcision, according to researchers at Rwanda's health ministry, Reuters reports.

21 Jan 2010

QuantRx Biomedical's developments in genetics-based technology

QuantRx® Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today provided an update from Chairman and Chief Executive Officer Walter Witoshkin on its involvement in genetics-based personalized medicine and disease prevention.

20 Jan 2010

National Institutes of Mental Health awards $8M for HIV research

A multidisciplinary research team at the Johns Hopkins University School of Medicine has been awarded $8 million in funding by the National Institutes of Mental Health to develop methods to rid the body of HIV.

20 Jan 2010

Rescue, relief efforts continue in Haiti, 200,000 people estimated to have perished in quake

Rescue efforts continue in Haiti after a major earthquake hit the country last week, CNN reports (1/18). While teams still search for survivors under the rubble, the priority is shifting to relief for those who survived the quake, according to Nicholas Reader, spokesperson for the U.N. Offices for the Coordination of Humanitarian Affairs, TIME reports (Newton-Small, 1/18).

20 Jan 2010

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Sangamo BioSciences, Inc. announced today that preliminary data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were presented on Friday, January 15, 2010 at the Keystone Symposium Session "HIV Biology and Pathogenesis."

20 Jan 2010

CytoDyn commences enrollment in Cytolin clinical trial

Following approval of the Institutional Review Board, CytoDyn, Inc. has discharged its duty to register a clinical trial of Cytolin®, the Company’s lead product, with the government’s website at www.clinicaltrials.gov, ID NCT01048372. The public has online access to this federal database, which describes the key elements of clinical trials and their status.

19 Jan 2010

California limits HMO wait times

The regulations by the California Department of Managed Health Care, in the works for much of the last decade, will require that patients be treated by HMO doctors within 10 business days of requesting an appointment, and by specialists within 15.

19 Jan 2010

National cross country HIV testing tour in Phoenix

The AHF/Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, rolls into Phoenix, Arizona, for a testing event from 12 p.m. to 5 p.m., Tuesday, January 19th. Free testing will take place on AHF’s new, state-of-the-art ‘Testing America’ mobile HIV testing unit at the One Voice LGBT Community Center (725 West Indian Road, Phoenix, 85013).

19 Jan 2010

Abbott to provide critical pharmaceutical and nutritional products for Haiti relief efforts

Working directly with humanitarian partners to help address the growing health care crisis, Abbott is expanding its support for relief efforts in Haiti. The company will provide $2.5 million in grant funding and donations of critical pharmaceutical and nutritional products to humanitarian aid organizations.

19 Jan 2010

CARE's disaster-response teams teach water purification techniques in earthquake-ravaged Haiti

CARE's disaster-response teams find themselves in a race against time in earthquake-ravaged Haiti, coaching survivors how to purify contaminated water and preparing hygiene kits to help prevent a secondary crisis: the outbreak of disease.

19 Jan 2010

Tragic consequences of AIDS denialism in South Africa

Despite irrefutable proof that HIV treatments have proven benefits, AIDS denialists continue to deny their value. In a paper just published online in Springer's journal AIDS and Behavior, Professor Myron Essex and Dr. Pride Chigwedere, from the Harvard School of Public Health AIDS Initiative in the US, provide additional proof that withholding HIV treatments with proven benefits led to the death of 330,000 people in South Africa as the result of AIDS denialist policies. They also show that the harm has not been reversed and highlight that when denialism enters public health practice, as in South Africa, the consequences are disastrous.

19 Jan 2010

Voice abnormalities in cochlear implants will improve over time, says study

Children with cochlear implants in both ears appear to have difficulty controlling the loudness and pitch of their voices, but these measures improve over time, according to a report in the January issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

19 Jan 2010

Babraham Institute research may lead to new means of making purified T cells

Research from the Babraham Institute, reported today in the Journal of Experimental Medicine, provides new insights into how our immune system produces T cells, a type of white blood cell that is an essential part of the body's immune surveillance system for fighting infection. The findings pave the way for a new means of making purified T cells, which gets over one of many hurdles faced in the use of T cells in regenerative medicine and transplantations, and in addition will open up new avenues of research and applications in drug and toxicity testing in industry.

18 Jan 2010

New book on harnessing science and innovation to tackle challenges in poor countries

Science and Innovation for Development demonstrates how science and innovation can be harnessed to tackle today's biggest challenges in poor countries, including climate change, HIV/AIDS and illiteracy. Case studies are described, including the use of tissue culture to develop disease-resistant bananas in Kenya; the use of nanotechnology to develop cheaper and faster kits for diagnosing infectious diseases and the use of organic material to power a multi-purpose stove that can also function as a refrigerator and generator.

18 Jan 2010

Plan launches international appeal to support its emergency operations in Haiti’s affected areas

Aid workers from children's charity Plan International are in a race to help survivors of the devastating Haiti earthquake cope with the aftermath.

18 Jan 2010

Obama's latest dilemma: Confronting the AIDS pandemic

Confronting the ongoing AIDS pandemic for his upcoming first national HIV/AIDS Strategy is President Obama's newest dilemma, say former New York City Mayor Ed Koch, former White House Drug Policy spokesman Robert Weiner, and Dartmouth College Coalition for Progress president Jordan Osserman.

18 Jan 2010

AIDS News and Research

Study: PrEP treatment offers protection against HIV transmission in humanized mice

New class of HCV inhibitors discovered by Eiger BioPharmaceuticals

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Opinions: Haiti relief, recovery efforts

Circumcising newborn males cost effective strategy for HIV prevention, Rwandan study finds

QuantRx Biomedical's developments in genetics-based technology

National Institutes of Mental Health awards $8M for HIV research

Rescue, relief efforts continue in Haiti, 200,000 people estimated to have perished in quake

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

CytoDyn commences enrollment in Cytolin clinical trial

California limits HMO wait times

National cross country HIV testing tour in Phoenix

Abbott to provide critical pharmaceutical and nutritional products for Haiti relief efforts

CARE's disaster-response teams teach water purification techniques in earthquake-ravaged Haiti

Tragic consequences of AIDS denialism in South Africa

Voice abnormalities in cochlear implants will improve over time, says study

Babraham Institute research may lead to new means of making purified T cells

New book on harnessing science and innovation to tackle challenges in poor countries

Plan launches international appeal to support its emergency operations in Haiti’s affected areas

Obama's latest dilemma: Confronting the AIDS pandemic

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News